Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI ...

These statements relate to, among other things, the anticipated benefits and impact of the AI-driven peptide discovery pipeline, the potential for computationally designed GLP-1 analogs to improve ...

The following is a summary of “Treatment of Hypothalamic Obesity With GLP-1 Analogs,” published in the November 2024 issue of Endocrinology by Dimitri and Roth. Damage to hypothalamic nuclei or ...

To prevent rapid weight loss, Chadha refrains from incrementing patients’ doses of GLP-1 analogs every 4 weeks, she said. Instead, she increases the dose when patients start to plateau on the ...

Liraglutide is a GLP-1 analog, which is resistant to degradation. Phase III trials have demonstrated that liraglutide effectively controls glucose levels, while reducing bodyweight.

About MET-097i MET-097i, Metsera’s most advanced product candidate, is a fully-biased, potential once-monthly, ultra-long acting, subcutaneously injectable GLP-1 receptor agonist. Positive 12 ...